These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 26984797)

  • 1. D3 dopamine receptor mRNA expression in lymphocytes: a peripheral marker for schizophrenia?
    van der Weide J; W Steijns LS; van der Geld MA; de Groot PA
    Acta Neuropsychiatr; 2003 Apr; 15(2):91-3. PubMed ID: 26984797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased levels of dopamine D3 receptor mRNA in schizophrenic and bipolar patients.
    Vogel M; Pfeifer S; Schaub RT; Grabe HJ; Barnow S; Freyberger HJ; Cascorbi I
    Neuropsychobiology; 2004; 50(4):305-10. PubMed ID: 15539862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients.
    Kwak YT; Koo MS; Choi CH; Sunwoo I
    BMC Med Genet; 2001; 2():3. PubMed ID: 11252158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the dopamine D3 receptor mRNA on blood lymphocytes help to for identification and subtyping of schizophrenia?
    Urhan-Kucuk M; Erdal ME; Ozen ME; Kul S; Herken H
    Mol Biol Rep; 2011 Apr; 38(4):2569-72. PubMed ID: 21110120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peripheral marker for schizophrenia: Increased levels of D3 dopamine receptor mRNA in blood lymphocytes.
    Ilani T; Ben-Shachar D; Strous RD; Mazor M; Sheinkman A; Kotler M; Fuchs S
    Proc Natl Acad Sci U S A; 2001 Jan; 98(2):625-8. PubMed ID: 11149951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells.
    Boneberg EM; von Seydlitz E; Pröpster K; Watzl H; Rockstroh B; Illges H
    J Neuroimmunol; 2006 Apr; 173(1-2):180-7. PubMed ID: 16376996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Over-expression of dopamine D2 receptor and inwardly rectifying potassium channel genes in drug-naive schizophrenic peripheral blood lymphocytes as potential diagnostic markers.
    Zvara A; Szekeres G; Janka Z; Kelemen JZ; Cimmer C; Sántha M; Puskás LG
    Dis Markers; 2005; 21(2):61-9. PubMed ID: 15920292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia?
    Mehler-Wex C; Duvigneau JC; Hartl RT; Ben-Shachar D; Warnke A; Gerlach M
    Eur Child Adolesc Psychiatry; 2006 Dec; 15(8):504-7. PubMed ID: 16788776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of the Ser9Gly polymorphism in the dopamine D3 receptor gene with tardive dyskinesia in Korean schizophrenics.
    Woo SI; Kim JW; Rha E; Han SH; Hahn KH; Park CS; Sohn JW
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):469-74. PubMed ID: 12109967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No association between schizophrenia and homozygosity at the D3 dopamine receptor gene.
    Yang L; Li T; Wiese C; Lannfelt L; Sokoloff P; Xu CT; Zeng Z; Schwartz JC; Liu X; Moises HW
    Am J Med Genet; 1993 Jul; 48(2):83-6. PubMed ID: 8103292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Correlation between the effectiveness of atypical antipsychotics and dopamine D3 receptor polymorphism in schizophrenia].
    Szekeres G; Juhász A; Kéri S; Rimanóczy A; Szendi I; Szabó Z; Janka Z
    Ideggyogy Sz; 2002 Nov; 55(11-12):377-81. PubMed ID: 12632798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A peripheral marker for schizophrenia: increased levels of D3-receptor-mRNA in blood lymphocytes].
    Känzig S
    Psychiatr Prax; 2001 Jul; 28(5):251-2. PubMed ID: 11517916
    [No Abstract]   [Full Text] [Related]  

  • 13. D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes.
    Vile JM; Strange PG
    Biol Psychiatry; 1996 Nov; 40(9):881-5. PubMed ID: 8896774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacogenetic assessment of antipsychotic-induced tardive dyskinesia: contribution of 5-hydroxytryptamine 2C receptor gene and of a combination of dopamine D3 variant allele (Gly) and MnSOD wild allele (Val)].
    Zhang Z; Hou G; Zhang X; Yao H; Sha W; Zhang X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Apr; 20(2):98-102. PubMed ID: 12673575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association study between schizophrenia and dopamine D3 receptor gene polymorphism.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Takahashi M; Maeda M; Kameda K; Tsuji S; Ihda S
    Am J Med Genet; 1996 Jul; 67(4):366-8. PubMed ID: 8837704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor D3 mRNA expression in human lymphocytes is negatively correlated with the personality trait of persistence.
    Czermak C; Lehofer M; Renger H; Wagner EM; Lemonis L; Rohrhofer A; Schauenstein K; Liebmann PM
    J Neuroimmunol; 2004 May; 150(1-2):145-9. PubMed ID: 15081259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes.
    Perl O; Ilani T; Strous RD; Lapidus R; Fuchs S
    FASEB J; 2003 Oct; 17(13):1948-50. PubMed ID: 12897067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
    Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence of no linkage between schizophrenia and the dopamine D3 receptor gene locus.
    Nanko S; Fukuda R; Hattori M; Sasaki T; Dai XY; Yamaguchi K; Kazamatsuri H
    Am J Med Genet; 1994 Sep; 54(3):264-7. PubMed ID: 7810586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.